Content from our Sponsor Fibroids

Article

Dr. Charles E. Miller resects a 1.7cm Type I Myoma in 3 minutes and 37 seconds performs a Myomectomy using the TRUCLEAR ULTRA Reciprocating Morcellator 4.0 Dr. Dick Schoot removes multiple Type 1 and Type II Myomas using the TRUCLEAR ULTRA Reciprocating Morcellator 4.0 Dr. Melissa Anderson performs a Polypectomy resecting multiple polyps using the TRUCLEAR 8.0 System.

Dr. Charles E. Miller resects a 1.7cm Type I Myoma in 3 minutes and 37 seconds performs a Myomectomy using the TRUCLEAR ULTRA Reciprocating Morcellator 4.0 Dr. Dick Schoot removes multiple Type 1 and Type II Myomas using the TRUCLEAR ULTRA Reciprocating Morcellator 4.0 Dr. Melissa Anderson performs a Polypectomy resecting multiple polyps using the TRUCLEAR 8.0 System.

Recent Videos
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Related Content
FDA updates warning for liver injury due to fezolinetant

FDA adds boxed warning to fezolinetant for rare serious liver injury

Kevin Kunzmann;Morgan Ebert, Managing Editor
Published: December 17th 2024 | Updated: December 17th 2024
Article

The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

Predicting postoperative nausea and vomiting with a new model | Image Credit: © leszekglasner - © leszekglasner - stock.adobe.com.

Predicting postoperative nausea and vomiting with a new model

Celeste Krewson, Assistant Editor
December 16th 2024
Article

A new predictive model, proven reliable and highly accurate, helps identify high-risk patients for postoperative nausea and vomiting, improving outcomes after gynecologic laparoscopic procedures.

Read More

Site Logo

The Importance of Including Hemoglobinopathies as a Part of Carrier Screening Panels

September 15th 2023
Podcast

Listen

Counseling patients following early pregnancy loss | Image Credit: © nicoletaionescu - © nicoletaionescu - stock.adobe.com.

Counseling patients following early pregnancy loss

Sheeva Yazdani DO, MPH, MS;Anne Nichols Flynn, MD, MSHP
December 13th 2024
Article

Read More

Image credit: © Moschiorini - stock.adobe.com.

Study finds early HPV vaccination boosts completion rates

Morgan Ebert, Managing Editor
December 13th 2024
Article

Early HPV vaccination at age 9 boosts completion rates, reduces disparities, and enhances cancer prevention effort, according to a recent study from Nemours Children's Health.

Read More

© 2024 MJH Life Sciences

All rights reserved.